Clinical Trials
Showing trials with last updates posted in 2025.
26
Participants
Role of Aging and Individual Variation in Exercise Training Responsiveness
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2025-04-02
Completion:
2027-03-31
Conditions
Prediabetic State
Cardiovascular Diseases
Insulin Resistance
Obesity
Interventions
BEHAVIORAL
No Results Yet
80
Participants
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2025-01-07
Completion:
2026-07-31
Conditions
CTCL/ Mycosis Fungoides
CTCL
Mycosis Fungoides
Cutaneous T Cell Lymphoma
Interventions
DRUG
No Results Yet
28
Participants
High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-06-03
Completion:
2024-09-15
Conditions
Diabetic Foot Ulcer (DFU)
Interventions
DEVICE
OTHER
365
Participants
A Study of SGN-MesoC2 in Advanced Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-02
Completion:
2028-05-01
Conditions
Carcinoma, Non-Small-Cell Lung
Ovarian Neoplasms
Pancreatic Adenocarcinoma
Colorectal Neoplasms
Mesothelioma
Other Solid Tumors
Endometrial
Interventions
DRUG
No Results Yet
105
Participants
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-19
Completion:
2025-12-31
Conditions
Adenoid Cystic Carcinoma
Colorectal Cancer
Interventions
DRUG
No Results Yet
410
Participants
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2022-07-12
Completion:
2030-07-12
Conditions
Breast Carcinoma
Kidney Carcinoma
Carcinoma
Interventions
PROCEDURE
OTHER
No Results Yet
50
Participants
Testing STAR and TexSTAR: A Video and Text Messaging Intervention
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2025-03-12
Completion:
2025-12-31
Conditions
Sexual Violence
Posttraumatic Stress Disorder
Opioid Use
Opioid Misuse
Interventions
BEHAVIORAL
No Results Yet
72
Participants
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-29
Completion:
2026-06-30
Conditions
Postpartum Hemorrhage
Immediate Postpartum Hemorrhage
Hemorrhage, Postpartum
Interventions
DEVICE
No Results Yet
60
Participants
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-06-07
Completion:
2026-01-31
Conditions
Dehydration
Heat Stress
Interventions
OTHER
No Results Yet
60
Participants
Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-07-01
Completion:
2025-11-12
Conditions
COVID-19
Interventions
BIOLOGICAL
No Results Yet
540
Participants
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-07-31
Completion:
2026-08-31
Conditions
Hot Flashes
Interventions
DRUG
No Results Yet
315
Participants
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-10-24
Completion:
2029-03-23
Conditions
Sickle Cell Disease
Interventions
BIOLOGICAL
DRUG
No Results Yet
150
Participants
Neuropathic Pain and it's Relation to Sleep Quality in Knee Osteoarthritis
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-16
Completion:
2026-12-01
Conditions
Knee Osteoarthritis
Sleep Disturbance
Neuropathic Pain
Interventions
OTHER
No Results Yet
1200
Participants
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-06-05
Completion:
2028-10-30
Conditions
Crohn's Disease
Interventions
DRUG
OTHER
No Results Yet
26
Participants
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-02-09
Completion:
2026-08-31
Conditions
Pancreatic Cancer
Interventions
BEHAVIORAL
No Results Yet
35
Participants
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-01
Completion:
2027-04-30
Conditions
Pediatric Cancer
Interventions
OTHER
No Results Yet
40
Participants
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2025-03-28
Completion:
2026-12-31
Conditions
Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
130
Participants
Automated Insulin Delivery for Inpatients With Dysglycemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2025-01-22
Completion:
2025-10-31
Conditions
Type 1 Diabetes
Type 2 Diabetes
Interventions
DEVICE
COMBINATION_PRODUCT
No Results Yet
54
Participants
The Effect of Schroth Exercises on Cerebral Cortical Thickness and Motor and Proprioceptive Fibres
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-01
Completion:
2024-12-30
Conditions
Adolescent Idiopathic Scoliosis
Interventions
OTHER
No Results Yet
30
Participants
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-07-23
Completion:
2029-05-12
Conditions
Recurrent Glioblastoma, IDH-Wildtype
Recurrent WHO Grade 2 Glioma
Recurrent WHO Grade 3 Glioma
Recurrent WHO Grade 4 Glioma
Interventions
DRUG
PROCEDURE
OTHER
No Results Yet
1500
Participants
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-08
Completion:
2026-06-29
Conditions
Dermatitis Atopic
Interventions
DRUG
No Results Yet
660
Participants
RECOVER-ENERGIZE Platform Protocol
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-07-17
Completion:
2025-10-30
Conditions
Long COVID
Long Covid19
Long Covid-19
Interventions
BEHAVIORAL
OTHER
No Results Yet
35
Participants
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2018-10-15
Completion:
2023-01-27
Conditions
Advanced Lymphoma
Advanced Malignant Solid Neoplasm
Refractory Lymphoma
Refractory Malignant Solid Neoplasm
Refractory Multiple Myeloma
Interventions
PROCEDURE
DRUG
180
Participants
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-09-04
Completion:
2026-04-30
Conditions
Chronic Kidney Disease
Hypertension
Interventions
BEHAVIORAL
No Results Yet
90
Participants
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-16
Completion:
2029-03-31
Conditions
B-cell Acute Lymphoblastic Leukemia
Diffuse Large B-cell Lymphoma
Burkitt Lymphoma
Neuroblastoma
Ewing Sarcoma
Interventions
BIOLOGICAL
No Results Yet
2
Participants
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-10
Completion:
2027-04-30
Conditions
Pancreatic Cancer
Locally Advanced Pancreatic Cancer
Interventions
DRUG
DEVICE
No Results Yet
1680
Participants
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2023-11-08
Completion:
2027-11-30
Conditions
Colorectal Carcinoma
Interventions
OTHER
No Results Yet
8
Participants
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2023-09-27
Completion:
2024-04-18
Conditions
Malignant Digestive System Neoplasm
Interventions
PROCEDURE
OTHER
No Results Yet
110
Participants
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-22
Completion:
2027-04-22
Conditions
Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma
Interventions
DRUG
PROCEDURE
BIOLOGICAL
OTHER
RADIATION
No Results Yet
143
Participants
A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-15
Completion:
2025-03-06
Conditions
Chronic Kidney Diseases
Chronic Kidney Insufficiency
Chronic Renal Diseases
Chronic Renal Insufficiency
Kidney Insufficiency, Chronic
C-Reactive Protein
High Sensitivity C-Reactive Protein
Hs-CRP
hsCRP
Interventions
DRUG
OTHER
No Results Yet
88
Participants
Psychoeducation of Adult Siblings of ASD People (Autism Spectrum Disorder).
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-03-28
Completion:
2024-10-30
Conditions
Autism Spectrum Disorder
Sibling Relations
Interventions
OTHER
No Results Yet
600
Participants
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-24
Completion:
2029-02-19
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG
OTHER
BIOLOGICAL
No Results Yet
54
Participants
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-04
Completion:
2027-03-31
Conditions
Rectal Cancer
Non-Small Cell Lung Cancer
Interventions
OTHER
No Results Yet
32
Participants
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-09-01
Completion:
2025-11-06
Conditions
Peanut Allergy
Interventions
DRUG
No Results Yet
874
Participants
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-01
Completion:
2026-02-28
Conditions
Migraine
Interventions
DRUG
No Results Yet
20
Participants
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-01
Completion:
2025-05-26
Conditions
Pancreatic Cancer
Interventions
BEHAVIORAL
No Results Yet
178
Participants
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-05-15
Completion:
2027-04-30
Conditions
Diabetic Retinopathy
Interventions
DRUG
No Results Yet
1200
Participants
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-04-14
Completion:
2027-07-11
Conditions
Breast Neoplasms
Interventions
DRUG
BIOLOGICAL
No Results Yet
300
Participants
A Study to Assess Growth in Children With Idiopathic Short Stature
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-08
Completion:
2040-12-31
Conditions
Idiopathic Short Stature
No Results Yet
12
Participants
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-14
Start Date:
2024-08-14
Completion:
2029-02-01
Conditions
Leiomyosarcoma
Soft-tissue Sarcomas
Interventions
DRUG
No Results Yet
Showing 40 trials per page · Total 108293 trials